ACTH and alpha-MSH: cardiovascular and antiarrhythmic properties.
D000324:Adrenocorticotropic Hormone / Q000494:pharmacology*; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects; D002415:Cats; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D004562:Electrocardiography; D005260:Female; D006168:Guinea Pigs; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects*; D066298:In Vitro Techniques; D008297:Male; D009074:Melanocyte-Stimulating Hormones / Q000494:pharmacology*; D011433:Propranolol / Q000494:pharmacology; D011817:Rabbits; D051381:Rats; D013045:Species Specificity; D013268:Stimulation, Chemical; D013328:Strophanthins / Q000494:pharmacology
D000889:Anti-Arrhythmia Agents; D013328:Strophanthins; D000324:Adrenocorticotropic Hormone; D009074:Melanocyte-Stimulating Hormones; D011433:Propranolol